NASDAQ : AVGR

Avinger, Inc.

$0.474 USD

-$0.12 (-20.74%)

Volume
2.59M
Average Volume
3.2M
Market Capitalization
$1.52M
P/E Ratio
-0.02
Dividend Yield
0.00%
Price Target
Year High
$4.37
Year Low
$0.36
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.63
Company Overview

NASDAQ

Nabeel P. Subainati CPA

Medical - Instruments & Supplies

Healthcare

AVGR

68

US

USD

https://avinger.com

650 241 7900

053734877

0001506928

Liquidity Metrics

-2.48

0.63

0.36

0.27

0.00

Sales & Valuation

$7.65M

0.20

-0.06

-0.10

-18.37

Profitability

-$23.31

-$18.32M

-239.41%

-239.41%

1782.10%

-133.04%

P/E Metrics

-0.02

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

7 Analysts

%

Poll Results

About Avinger, Inc. (NASDAQ:AVGR) Stock

Avinger, Inc. is a commercial-stage medical technology firm that develops, manufactures, and markets sophisticated image-guided, catheter-based systems. These devices are utilized by physicians both domestically and internationally to treat patients suffering from Peripheral Arterial Disease (PAD). Central to Avinger's offerings is its proprietary lumivascular platform. This innovative technology integrates Optical Coherence Tomography (OCT) visualization directly into interventional catheters, providing real-time, intravascular imaging to guide doctors during PAD procedures. The company's lumivascular product suite includes the Lightbox imaging consoles, as well as the Ocelot family of catheters, which are specifically designed to help physicians penetrate complete arterial blockages. Add ... itionally, the Pantheris is an image-guided atherectomy device enabling precise removal of plaque from affected arteries. Avinger also offers its earlier-generation Chronic Total Occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2. These employ a unique rotational spinning technique, allowing physicians to switch between passive and active modes when navigating difficult CTOs. Furthermore, the company is developing IMAGE-BTK, a specialized solution for treating PAD lesions located below-the-knee. Avinger's advanced medical devices are sold to a specialized clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists. The company was founded in 2007 and is headquartered in Redwood City, California.

Frequently Asked Questions

What is the current Avinger, Inc. (AVGR) stock price?

Avinger, Inc.(NASDAQ:AVGR) stock price is $0.474 in the last trading session. During the trading session, AVGR stock reached the peak price of $4.3689 while $0.363 was the lowest point it dropped to. The percentage change in AVGR stock occurred in the recent session was --20.74% while the dollar amount for the price change in AVGR stock was -$0.12.

AVGR's industry and sector of operation?

The NASDAQ listed AVGR is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of AVGR?

Nabeel Subainati | Vice President of Finance, Principal Financial Officer & Principal Accounting Officer
Jaafer Golzar | Chief Medical Officer
Philip R. Preuss | Chief Commercial Officer
|
|

How many employees does AVGR have?

Number of AVGR employees currently stands at 68. AVGR operates from 400 Chesapeake Drive, Redwood City, CA 94063, US.

Link for AVGR official website?

Official Website of AVGR is: https://avinger.com

How do I contact AVGR?

AVGR could be contacted at phone #650 241 7900 and can also be accessed through its website. AVGR operates from 400 Chesapeake Drive, Redwood City, CA 94063, US.

How many shares of AVGR are traded daily?

The average number of AVGR shares traded daily for last 3 months was 3.2M.

What is the market cap of AVGR currently?

The market value of AVGR currently stands at $1.52M with its latest stock price at $0.474